gms | German Medical Science

65. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

11. - 14. Mai 2014, Dresden

Embryonic stem cell markers in human gliomas

Meeting Abstract

  • Dorothee Engel - Universität Kiel, Anatomisches Institut, Kiel
  • Kirsten Hattermann - Universität Kiel, Anatomisches Institut, Kiel
  • Maximilian H. Mehdorn - Universitätsklinikum Schleswig-Holstein, Campus Kiel, Neurochirurgische Klinik, Kiel
  • Rolf Mentlein - Universität Kiel, Anatomisches Institut, Kiel
  • Janka Held-Feindt - Universitätsklinikum Schleswig-Holstein, Campus Kiel, Neurochirurgische Klinik, Kiel

Deutsche Gesellschaft für Neurochirurgie. 65. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC). Dresden, 11.-14.05.2014. Düsseldorf: German Medical Science GMS Publishing House; 2014. DocP 072

doi: 10.3205/14dgnc468, urn:nbn:de:0183-14dgnc4681

Veröffentlicht: 13. Mai 2014

© 2014 Engel et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Objective: As early as in 1858 Rudolf Virchow assumed that cancer arises from embryo-like cells. In this later extended concept (embryonal rest theory) aggressive cancer cells share histological similarities to embryonic stem cells. As differentiated cells acquire embryonic pluripotency and self-renewal by transfection with transcription factors like Oct4, Sox2, Nanog, Klf4 and c-Myc, we investigated their occurrence and frequency in human astrocytomas and glioma cell lines.

Method: Gene transcription was analyzed by quantitative RT-PCR and protein expression by immunohistochemistry. Positive cells were counted by an unbiased person for single or multiple expressions.

Results: Tumor samples showed a moderate to high mRNA expression of all transcription factors, with Sox2 and c-Myc as most pronounced. Among astrocytomas of different WHO grades, expression of c-Myc, Oct 4 and Sox2 increases with malignancy. As in solid tumors, Sox2 and c-Myc were most abundantly expressed also in glioblastoma cells lines, Nanog and Klf4 were expressed only at low levels. Co-staining with glial-specific markers proved an expression of all transcription factors in astrocytoma cells in situ and in vitro. However, in solid tumors expression was restricted to a subpopulation of cells ranging from 5-10% for all factors. Furthermore, cells positive for one transcription factor frequently co-stained for another factor, but single positive cells were also found in different proportions.

Conclusions: We conclude that human astrocytomas contain a low, but constant proportion of cells expressing embryonic and/or neural stem cell factors, some increasing with malignancy. Investigations are undergoing to relate them to further characteristics, e. g. receptors for growth and chemotaxis factors.